These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18581132)

  • 21. [Management of Graves' orbitopathy: evidence-based recommendations].
    Ponto KA; Pitz S; Mann WJ; Weber MM; Pfeiffer N; Kahaly GJ
    Dtsch Med Wochenschr; 2009 Dec; 134(49):2521-4. PubMed ID: 19941237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knowledge of Thyroid Eye Disease in Graves' Disease Patients With and Without Orbitopathy.
    Edmunds MR; Boelaert K
    Thyroid; 2019 Apr; 29(4):557-562. PubMed ID: 30688164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of patients with Graves' orbitopathy: initial assessment, management outside specialised centres and referral pathways.
    Perros P; Dayan CM; Dickinson AJ; Ezra D; Estcourt S; Foley P; Hickey J; Lazarus JH; MacEwen CJ; McLaren J; Rose GE; Uddin J; Vaidya B
    Clin Med (Lond); 2015 Apr; 15(2):173-8. PubMed ID: 25824071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early versus late orbital decompression in Graves' orbitopathy: a retrospective study in 125 patients.
    Baldeschi L; Wakelkamp IM; Lindeboom R; Prummel MF; Wiersinga WM
    Ophthalmology; 2006 May; 113(5):874-8. PubMed ID: 16530839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pediatric Graves' ophthalmopathy: the pre- and postpubertal experience.
    Holt H; Hunter DG; Smith J; Dagi LR
    J AAPOS; 2008 Aug; 12(4):357-60. PubMed ID: 18359653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Comparative Study of Full-Thickness Blepharotomy Versus Transconjunctival Eyelid Lengthening in the Correction of Upper Eyelid Retraction in Graves' Orbitopathy.
    Gonçalves ACP; Nogueira T; Gonçalves ACA; Silva LD; Matayoshi S; Monteiro MLR
    Aesthetic Plast Surg; 2018 Feb; 42(1):215-223. PubMed ID: 29026936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcome of Graves' orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapy.
    Sisti E; Menconi F; Leo M; Profilo MA; Mautone T; Mazzi B; Rocchi R; Latrofa F; Nardi M; Vitti P; Marcocci C; Marinò M
    J Endocrinol Invest; 2015 Jun; 38(6):661-8. PubMed ID: 25596664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Graves' orbitopathy].
    Eckstein A; Esser J
    Klin Monbl Augenheilkd; 2011 May; 228(5):432-8. PubMed ID: 21534176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating Graves' orbitopathy.
    Dolman PJ
    Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):229-48. PubMed ID: 22632361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Orbital-bony decompression in patients with dysthyroid orbitopathy--first Croatian experiences].
    Juri J; Stiglmayer N; Kuzman T
    Acta Med Croatica; 2006; 60(2):83-6. PubMed ID: 16848193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with severity of orbitopathy in patients with Graves' disease.
    Nabi T; Rafiq N
    Taiwan J Ophthalmol; 2020; 10(3):197-202. PubMed ID: 33110751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of orbital decompression for disfiguring proptosis in patients with Graves' orbitopathy using various surgical procedures.
    ; Mourits MP; Bijl H; Altea MA; Baldeschi L; Boboridis K; Currò N; Dickinson AJ; Eckstein A; Freidel M; Guastella C; Kahaly GJ; Kalmann R; Krassas GE; Lane CM; Lareida J; Marcocci C; Marino M; Nardi M; Mohr Ch; Neoh C; Pinchera A; Orgiazzi J; Pitz S; Saeed P; Salvi M; Sellari-Franceschini S; Stahl M; von Arx G; Wiersinga WM
    Br J Ophthalmol; 2009 Nov; 93(11):1518-23. PubMed ID: 19028743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center.
    Tanda ML; Piantanida E; Liparulo L; Veronesi G; Lai A; Sassi L; Pariani N; Gallo D; Azzolini C; Ferrario M; Bartalena L
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1443-9. PubMed ID: 23408569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management plan and delivery of care in Graves' ophthalmopathy patients.
    Yang M; Perros P
    Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):303-11. PubMed ID: 22632367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life of patients with thyroid eye disease: 3-year follow-up in a multidisciplinary clinic in Israel.
    Zloto O; Sagiv O; Priel A; Cukierman-Yaffe T; Tirosh A; Agmon-Levin N; Madgar S; Serlin T; Ben Simon G
    Graefes Arch Clin Exp Ophthalmol; 2021 Jul; 259(7):2009-2015. PubMed ID: 33528651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of Graves ophthalmopathy - 2022 update.
    Jiskra J
    Cas Lek Cesk; 2022; 161(5):198-206. PubMed ID: 36443100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VARIABLES AFFECTING THE LONG-TERM OUTCOME OF GRAVES ORBITOPATHY FOLLOWING HIGH-DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY.
    Leo M; Mautone T; Ionni I; Profilo MA; Sabini E; Menconi F; Mazzi B; Rocchi R; Latrofa F; Nardi M; Vitti P; Marcocci C; Marinò M
    Endocr Pract; 2016 Oct; 22(10):1177-1186. PubMed ID: 27732097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study.
    Sabini E; Mazzi B; Profilo MA; Mautone T; Casini G; Rocchi R; Ionni I; Menconi F; Leo M; Nardi M; Vitti P; Marcocci C; Marinò M
    Thyroid; 2018 Mar; 28(3):386-394. PubMed ID: 29336220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changing trend in referral to secondary care specialist thyroid eye disease clinic following the Amsterdam declaration.
    Quinn AS; Dujardin LR; Knight B; Benzimra J; Quinn AG; Vaidya B
    Int Ophthalmol; 2018 Feb; 38(1):301-306. PubMed ID: 28181061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized controlled trial of rituximab in patients with Graves' orbitopathy.
    Stan MN; Garrity JA; Carranza Leon BG; Prabin T; Bradley EA; Bahn RS
    J Clin Endocrinol Metab; 2015 Feb; 100(2):432-41. PubMed ID: 25343233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.